embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

Core Points - Embecta Corp. is transitioning from a company focused solely on insulin delivery to a broader medical supplies company, leveraging its 100-year legacy in the industry [1][3] - The company will host a conference call on November 25, 2025, at 8:00 a.m. ET to discuss its fiscal fourth quarter and full year 2025 financial results, along with preliminary financial guidance for fiscal year 2026 [1][2] Company Overview - Embecta employs approximately 2,000 employees globally and aims to improve lives through innovative solutions and partnerships [3] - The company is committed to advancing its legacy in insulin delivery while expanding its product offerings in the medical supplies sector [3]